The DOI matches its Crossref record; 44 of the 44 references it cites were found in a registry or an index.
Global Incidence of Neurological Manifestations Among Patients Hospitalized With COVID-19—A Report for the GCS-NeuroCOVID Consortium and the ENERGY Consortium
Open accessAbstract
Importance: The COVID-19 pandemic continues to affect millions of people globally, with increasing reports of neurological manifestations but limited data on their incidence and associations with outcome. Objective: To determine the neurological phenotypes, incidence, and outcomes among adults hospitalized with COVID-19. Design, Setting, and Participants: This cohort study included patients with clinically diagnosed or laboratory-confirmed COVID-19 at 28 centers, representing 13 countries and 4 continents. The study was performed by the Global Consortium Study of Neurologic Dysfunction in COVID-19 (GCS-NeuroCOVID) from March 1 to September 30, 2020, and the European Academy of Neurology (EAN) Neuro-COVID Registry (ENERGY) from March to October 2020. Three cohorts were included: (1) the GCS-NeuroCOVID all COVID-19 cohort (n = 3055), which included consecutive hospitalized patients with COVID-19 with and without neurological manifestations; (2) the GCS-NeuroCOVID COVID-19 neurological cohort (n = 475), which comprised consecutive patients hospitalized with COVID-19 who had confirmed neurological manifestations; and (3) the ENERGY cohort (n = 214), which included patients with COVID-19 who received formal neurological consultation. Exposures: Clinically diagnosed or laboratory-confirmed COVID-19. Main Outcomes and Measures: Neurological phenotypes were classified as self-reported symptoms or neurological signs and/or syndromes assessed by clinical evaluation. Composite incidence was reported for groups with at least 1 neurological manifestation. The main outcome measure was in-hospital mortality. Results: Of the 3055 patients in the all COVID-19 cohort, 1742 (57%) were men, and the mean age was 59.9 years (95% CI, 59.3-60.6 years). Of the 475 patients in the COVID-19 neurological cohort, 262 (55%) were men, and the mean age was 62.6 years (95% CI, 61.1-64.1 years). Of the 214 patients in the ENERGY cohort, 133 (62%) were men, and the mean age was 67 years (95% CI, 52-78 years). A total of 3083 of 3743 patients (82%) across cohorts had any neurological manifestation (self-reported neurological symptoms and/or clinically captured neurological sign and/or syndrome). The most common self-reported symptoms included headache (1385 of 3732 patients [37%]) and anosmia or ageusia (977 of 3700 patients [26%]). The most prevalent neurological signs and/or syndromes were acute encephalopathy (1845 of 3740 patients [49%]), coma (649 of 3737 patients [17%]), and stroke (222 of 3737 patients [6%]), while meningitis and/or encephalitis were rare (19 of 3741 patients [0.5%]). Presence of clinically captured neurologic signs and/or syndromes was associated with increased risk of in-hospital death (adjusted odds ratio [aOR], 5.99; 95% CI, 4.33-8.28) after adjusting for study site, age, sex, race, and ethnicity. Presence of preexisting neurological disorders (aOR, 2.23; 95% CI, 1.80-2.75) was associated with increased risk of developing neurological signs and/or syndromes with COVID-19. Conclusions and Relevance: In this multicohort study, neurological manifestations were prevalent among patients hospitalized with COVID-19 and were associated with higher in-hospital mortality. Preexisting neurological disorders were associated with increased risk of developing neurological signs and/or syndromes in COVID-19.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Chen, N., Zhou, M., Dong, X., Qu, J., Gong, F., Han, Y., Qiu, Y., Wang, J., Liu, Y., Wei, Y., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30211-7 · Cited by 21,415
Neurologic manifestations of hospitalized patients with coronavirus disease 2019 in Wuhan, China
Mao, L., Jin, H., Wang, M., Hu, Y., Chen, S., He, Q., Chang, J., Hong, C., Zhou, Y., Wang, D., et al. (2020) · JAMA Neurology · doi:10.1001/jamaneurol.2020.1127 · Cited by 7,166
Neurologic features in severe SARS-CoV-2 infection
Helms, J., Kremer, S., Merdji, H., Clere-Jehl, R., Schenck, M., Kummerlen, C., Collange, O., Boulay, C., Fafi-Kremer, S., Ohana, M., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmc2008597 · Cited by 2,674
Neurological associations of COVID-19
Ellul, M. A., Benjamin, L., Singh, B., Lant, S., Michael, B. D., Easton, A., Kneen, R., Defres, S., Sejvar, J., & Solomon, T. (2020) · The Lancet Neurology · doi:10.1016/s1474-4422(20)30221-0 · Cited by 2,156
Large-Vessel Stroke as a Presenting Feature of Covid-19 in the Young
Oxley, T. J., Mocco, J., Majidi, S., Kellner, C. P., Shoirah, H., Singh, I. P., De Leacy, R. A., Shigematsu, T., Ladner, T. R., Yaeger, K. A., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmc2009787 · Cited by 2,116
Lodigiani, C., Iapichino, G., Carenzo, L., Cecconi, M., Ferrazzi, P., Sebastian, T., Kucher, N., Studt, J.-D., Sacco, C., Bertuzzi, A., et al. (2020) · Thrombosis Research · doi:10.1016/j.thromres.2020.04.024 · Cited by 2,054
Neuropathology of patients with COVID-19 in Germany: a post-mortem case series
Matschke, J., Lütgehetmann, M., Hagel, C., Sperhake, J. P., Schröder, A. S., Edler, C., Mushumba, H., Fitzek, A., Allweiss, L., Dandri, M., et al. (2020) · The Lancet Neurology · doi:10.1016/s1474-4422(20)30308-2 · Cited by 1,300
Guillain–Barré Syndrome Associated with SARS-CoV-2
Toscano, G., Palmerini, F., Ravaglia, S., Ruiz, L., Invernizzi, P., Cuzzoni, M. G., Franciotta, D., Baldanti, F., Daturi, R., Postorino, P., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmc2009191 · Cited by 1,260
Varatharaj, A., Thomas, N., Ellul, M. A., Davies, N. W. S., Pollak, T. A., Tenorio, E. L., Sultan, M., Easton, A., Breen, G., Zandi, M., et al. (2020) · The Lancet Psychiatry · doi:10.1016/s2215-0366(20)30287-x · Cited by 1,246
Li, Y., Li, M., Wang, M., Zhou, Y., Chang, J., Xian, Y., Wang, D., Mao, L., Jin, H., & Hu, B. (2020) · Stroke and Vascular Neurology · doi:10.1136/svn-2020-000431 · Cited by 1,066
Merkler, A. E., Parikh, N. S., Mir, S., Gupta, A., Kamel, H., Lin, E., Lantos, J., Schenck, E. J., Goyal, P., Bruce, S. S., et al. (2020) · JAMA Neurology · doi:10.1001/jamaneurol.2020.2730 · Cited by 940
Zubair, A. S., McAlpine, L. S., Gardin, T., Farhadian, S., Kuruvilla, D. E., & Spudich, S. (2020) · JAMA Neurology · doi:10.1001/jamaneurol.2020.2065 · Cited by 923
Central nervous system manifestations of COVID-19: A systematic review
Asadi-Pooya, A. A., & Simani, L. (2020) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2020.116832 · Cited by 774
SARS-CoV-2 and Stroke in a New York Healthcare System
Yaghi, S., Ishida, K., Torres, J., Mac Grory, B., Raz, E., Humbert, K., Henninger, N., Trivedi, T., Lillemoe, K., Alam, S., et al. (2020) · Stroke · doi:10.1161/strokeaha.120.030335 · Cited by 740
Characteristics of ischaemic stroke associated with COVID-19
Beyrouti, R., Adams, M. E., Benjamin, L., Cohen, H., Farmer, S. F., Goh, Y. Y., Humphries, F., Jäger, H. R., Losseff, N. A., Perry, R. J., et al. (2020) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp-2020-323586 · Cited by 711
Tong, J. Y., Wong, A., Zhu, D., Fastenberg, J. H., & Tham, T. (2020) · Otolaryngology–Head and Neck Surgery · doi:10.1177/0194599820926473 · Cited by 613
Frequent neurologic manifestations and encephalopathy‐associated morbidity in Covid‐19 patients
Liotta, E. M., Batra, A., Clark, J. R., Shlobin, N. A., Hoffman, S. C., Orban, Z. S., & Koralnik, I. J. (2020) · Annals of Clinical and Translational Neurology · doi:10.1002/acn3.51210 · Cited by 526
Self-citationRisk factors for Covid-19 severity and fatality: a structured literature review
Wolff, D., Nee, S., Hickey, N. S., & Marschollek, M. (2021) · Infection · doi:10.1007/s15010-020-01509-1 · Cited by 511
SARS-CoV-2 can induce brain and spine demyelinating lesions
Zanin, L., Saraceno, G., Panciani, P. P., Renisi, G., Signorini, L., Migliorati, K., & Fontanella, M. M. (2020) · Acta Neurochirurgica · doi:10.1007/s00701-020-04374-x · Cited by 380
Delirium and encephalopathy in severe COVID-19: a cohort analysis of ICU patients
Helms, J., Kremer, S., Merdji, H., Schenck, M., Severac, F., Clere-Jehl, R., Studer, A., Radosavljevic, M., Kummerlen, C., Monnier, A., et al. (2020) · Critical Care · doi:10.1186/s13054-020-03200-1 · Cited by 364
A Prospective Study of Neurologic Disorders in Hospitalized Patients With COVID-19 in New York City
Frontera, J. A., Sabadia, S., Lalchan, R., Fang, T., Flusty, B., Millar-Vernetti, P., Snyder, T., Berger, S., Yang, D., Granger, A., et al. (2021) · Neurology · doi:10.1212/wnl.0000000000010979 · Cited by 291
Self-citationAggarwal, G., Lippi, G., & Michael Henry, B. (2020) · International Journal of Stroke · doi:10.1177/1747493020921664 · Cited by 282
Neurological Implications of COVID-19 Infections
Needham, E. J., Chou, S. H.-Y., Coles, A. J., & Menon, D. K. (2020) · Neurocritical Care · doi:10.1007/s12028-020-00978-4 · Cited by 237
Self-citationBenussi, A., Pilotto, A., Premi, E., Libri, I., Giunta, M., Agosti, C., Alberici, A., Baldelli, E., Benini, M., Bonacina, S., et al. (2020) · Neurology · doi:10.1212/wnl.0000000000009848 · Cited by 228
Sex differential in COVID-19 mortality varies markedly by age
Bhopal, S. S., & Bhopal, R. (2020) · The Lancet · doi:10.1016/s0140-6736(20)31748-7 · Cited by 203
Mortality and survival of COVID-19
Sousa, G. J. B., Garces, T. S., Cestari, V. R. F., Florêncio, R. S., Moreira, T. M. M., & Pereira, M. L. D. (2020) · Epidemiology and Infection · doi:10.1017/s0950268820001405 · Cited by 182
Pleasure, S. J., Green, A. J., & Josephson, S. A. (2020) · JAMA Neurology · doi:10.1001/jamaneurol.2020.1065 · Cited by 171
New onset neurologic events in people with COVID-19 in 3 regions in China
Xiong, W., Mu, J., Guo, J., Lu, L., Liu, D., Luo, J., Li, N., Liu, J., Yang, D., Gao, H., et al. (2020) · Neurology · doi:10.1212/wnl.0000000000010034 · Cited by 162
Scoping review of prevalence of neurologic comorbidities in patients hospitalized for COVID-19
Herman, C., Mayer, K. P., & Sarwal, A. (2020) · Neurology · doi:10.1212/wnl.0000000000009673 · Cited by 141
Self-citationAnosmia is associated with lower in-hospital mortality in COVID-19
Talavera, B., García‐Azorín, D., Martínez‐Pías, E., Trigo-López, J., Hernández‐Pérez, I., Valle‐Peñacoba, G., Campo, P. S., de Lera, M., Chavarría‐Miranda, A., López‐Sanz, C., et al. (2020) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2020.117163 · Cited by 126
Majidi, S., Fifi, J. T., Ladner, T. R., Lara‐Reyna, J., Yaeger, K., Yim, B., Dangayach, N. S., Oxley, T. J., Shigematsu, T., Kummer, B. R., et al. (2020) · Stroke · doi:10.1161/strokeaha.120.030397 · Cited by 126
Moro, E., Priori, A., Beghi, E., Helbok, R., Campiglio, L., Bassetti, C. L., Bianchi, E., Maia, L. F., Öztürk, Ş., Cavallieri, F., et al. (2020) · European Journal of Neurology · doi:10.1111/ene.14407 · Cited by 124
Self-citationNeurological Comorbidity Is a Predictor of Death in Covid-19 Disease: A Cohort Study on 576 Patients
García‐Azorín, D., Martínez‐Pías, E., Trigo-López, J., Hernández‐Pérez, I., Valle‐Peñacoba, G., Talavera, B., Campo, P. S., de Lera, M., Chavarría‐Miranda, A., López‐Sanz, C., et al. (2020) · Frontiers in Neurology · doi:10.3389/fneur.2020.00781 · Cited by 99
Study, T. G.-N., Frontera, J. A., Mainali, S., Fink, E. L., Robertson, C., Schober, M. E., Ziai, W., Menon, D. K., Kochanek, P. M., Suárez, J. I., et al. (2020) · Neurocritical Care · doi:10.1007/s12028-020-00995-3 · Cited by 79
Self-citationHigh Prevalence of Headaches During Covid‐19 Infection: A Retrospective Cohort Study
Poncet‐Megemont, L., Paris, P., Tronchere, A., Salazard, J. P., Pereira, B., Dallel, R., Auméran, C., Beytout, J., Jacomet, C., Laurichesse, H., et al. (2020) · Headache The Journal of Head and Face Pain · doi:10.1111/head.13923 · Cited by 73
The negative impact of comorbidities on the disease course of COVID-19
Zádori, N., Váncsa, S., Farkas, N., Hegyi, P., Erőss, B. M., on behalf of the KETLAK Study Group, Szakó, L., Vörhendi, N., Frim, L., Dömötör, Z. R., et al. (2020) · Intensive Care Medicine · doi:10.1007/s00134-020-06161-9 · Cited by 59
Beghi, E., Helbok, R., Crean, M., Chou, S., McNett, M., Moro, E., Bassetti, C. L., & for the EAN Neuro‐COVID Task Force (2020) · European Journal of Neurology · doi:10.1111/ene.14652 · Cited by 55
Self-citationNeurological Predictors of Clinical Outcomes in Hospitalized Patients With COVID-19
Salahuddin, H., Afreen, E., Sheikh, I., Lateef, S., Dawod, G., Daboul, J., Karim, N., Gharaibeh, K., Al-Chalabi, M., Park, S., et al. (2020) · Frontiers in Neurology · doi:10.3389/fneur.2020.585944 · Cited by 48
Josephson, S. A., & Kamel, H. (2020) · JAMA · doi:10.1001/jama.2020.14254 · Cited by 46
NeuroCOVID: it's time to join forces globally
Helbok, R., Chou, S., Beghi, E., Mainali, S., Frontera, J. A., Robertson, C., Fink, E. L., Schober, M. E., Moro, E., McNett, M., et al. (2020) · The Lancet Neurology · doi:10.1016/s1474-4422(20)30322-7 · Cited by 45
Self-citationAcute encephalopathy is associated with worse outcomes in COVID-19 patients
Shah, V. A., Nalleballe, K., Zaghlouleh, M. E., & Onteddu, S. R. (2020) · Brain Behavior & Immunity - Health · doi:10.1016/j.bbih.2020.100136 · Cited by 36
The neurological impact of COVID-19
Neurology, T. L. (2020) · The Lancet Neurology · doi:10.1016/s1474-4422(20)30142-3 · Cited by 30
Neurologic Findings Among Inpatients With COVID-19 at a Safety-net US Hospital
Anand, P., Zhou, L., Bhadelia, N., Hamer, D. H., Greer, D. M., & Cervantes-Arslanian, A. M. (2020) · Neurology Clinical Practice · doi:10.1212/cpj.0000000000001031 · Cited by 22
Self-citationMcNett, M., Fink, E. L., Schober, M. E., Mainali, S., Helbok, R., Robertson, C., Mejía-Mantilla, J. H., Kurtz, P., Righy, C., Roa, J. D., et al. (2020) · Neurocritical Care · doi:10.1007/s12028-020-01100-4 · Cited by 17
Self-citation
Cited by
The neurobiology of long COVID
Monje, M., & Iwasaki, A. (2022) · Neuron · doi:10.1016/j.neuron.2022.10.006 · Cited by 415
“A wide range of neurological and neuropsychiatric symptoms are common features of acute COVID-19 (Helms et al., 2020; Mao et al., 2020; Varatharaj et al., 2020; Chou et al., 2021) and post-acute COVID-19 syndrome (PACS) (Nasserie et al., 2021), or long COVID.”
Pathogenesis of Alzheimer’s Disease
Rostagno, A. A. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms24010107 · Cited by 383
Single-cell and spatial transcriptomics: deciphering brain complexity in health and disease
Piwecka, M., Rajewsky, N., & Rybak-Wolf, A. (2023) · Nature Reviews Neurology · doi:10.1038/s41582-023-00809-y · Cited by 320
Neurological manifestations of long-COVID syndrome: a narrative review
Stefanou, M.-I., Palaiodimou, L., Bakola, E., Smyrnis, N., Papadopoulou, M., Paraskevas, G. P., Rizos, E., Boutati, E., Grigoriadis, N., Krogias, C., et al. (2022) · Therapeutic Advances in Chronic Disease · doi:10.1177/20406223221076890 · Cited by 263
Frontera, J. A., Tamborska, A. A., Doheim, M. F., Garcia‐Azorin, D., Gezegen, H., Guekht, A., Yusof Khan, A. H. K., Santacatterina, M., Sejvar, J., Thakur, K. T., et al. (2022) · Annals of Neurology · doi:10.1002/ana.26339 · Cited by 108
Self-citation
Metadata
- Authors
- Chou, S. H.-Y., Beghi, E., Helbok, R., Moro, E., Sampson, J., Altamirano, V., Mainali, S., Bassetti, C., Suarez, J. I., McNett, M., GCS-NeuroCOVID Consortium and ENERGY Consortium, Nolan, L., Temro, K., Cervantes-Arslanian, A. M., Anand, P., Mukerji, S., Alabasi, H., Westover, M. B., Kavi, T., John, S., Da Silva, I., Shaik, A., Sarwal, A., Izzy, S., Liotta, E. M., Batra, A., Aysenne, A., Rubinos, C., Azzam, A. Y., Azab, M. A., Sandall, J., Persondek, L. M., Ulmer, H., Rass, V., Pfausler, B., Müller, C., Jung, S., Crean, M., Meoni, S., Bereczki, D., Kovács, T., Agajany, N., Armon, C., Wolfson, S., Cotelli, M. S., Bianchi, E., Riahi, A., Öztürk, S., Ural, O., Viktoriia, G., Lesiv, M., Maia, L., Oliveira, V., Seabra, M., Carvalho, V., Vespa, P., Provencio, J., Olson, D., Hemphill, C., Venkatasubba Rao, C. P., Ko, N., Fink, E., Robertson, C., Schober, M., Smith Scott, A., Hammond, M., Paul, N., Safonova, A., Kaplan, L., Ratnayake, C., Sharma, A. D., Skeel, A., Villamizar Rosales, C., Dolak, D., Varelas, P., Lotman, L., Kaltenbach, L., & David K., M.
- Venue
- JAMA Network Open
- Publisher
- American Medical Association (AMA)
- Published
- 2021-05-11
- Volume
- 4
- Issue
- 5
- Pages
- e2112131
- ISSN
- 2574-3805 (ISSN-L)
- OpenAlex
- W3161773261
- Cited by
- 407
- References
- 44
- FWCI
- 35.96
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.